• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by ContraFect Corporation

    10/23/23 4:05:56 PM ET
    $CFRX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CFRX alert in real time by email
    DEFA14A 1 d539767ddefa14a.htm DEFA14A DEFA14A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

    SCHEDULE 14A

    (RULE 14a-101)

    INFORMATION REQUIRED IN PROXY STATEMENT

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

     

     

    Filed by the Registrant  ☒

    Filed by a Party other than the Registrant  ☐

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

     

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐

    Definitive Proxy Statement

     

    ☒

    Definitive Additional Materials

     

    ☐

    Soliciting Material Pursuant to §240.14a-12

    CONTRAFECT CORPORATION

    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if Other than Registrant)

    Payment of Filing Fee (check all boxes that apply):

     

    ☒

    No fee required

     

    ☐

    Fee paid previously with preliminary materials.

     

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     


    CONTRAFECT CORPORATION

    28 WELLS AVENUE, THIRD FLOOR

    YONKERS, NEW YORK 10701

    ContraFect Announces Adjournment of Special Meeting of Stockholders

    ContraFect Corporation (the “Company”) announced that today it convened its Special Meeting of Stockholders (“Special Meeting”) as scheduled for October 23, 2023. At the time of the Special Meeting, there were insufficient shares of the Company’s common stock present electronically or represented by proxy to constitute a quorum for the transaction of business at the Special Meeting. Accordingly, the Special Meeting was adjourned to allow for additional time to establish a quorum. The reconvened Special Meeting will be held at 9:00 a.m. Eastern Time on November 21, 2023 at www.virtualshareholdermeeting.com/CFRX2023SM. For information on how to attend the reconvened Special Meeting online and submit questions during the meeting, please see the information in the Company’s definitive proxy statement filed with the SEC on September 25, 2023.

    The record date for determining stockholders eligible to vote at the Special Meeting remains September 12, 2023. During the period of adjournment, the Company will continue to accept stockholder votes and any stockholders who have not yet voted are encouraged to do so. The Company encourages any eligible stockholder that has not yet voted their shares or provided voting instructions to their broker or other record holders to do so promptly. Any stockholders who have already voted or submitted a proxy do not need to take any further action unless they wish to change their vote. Stockholders who need help voting their shares may call the Company’s proxy solicitor, D.F. King & Co. at (800) 967-5079.

     

    1

    Get the next $CFRX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CFRX

    DatePrice TargetRatingAnalyst
    7/14/2022$1.00Outperform → Mkt Perform
    SVB Leerink
    7/14/2022$15.00 → $1.00Overweight → Neutral
    Cantor Fitzgerald
    2/16/2022$14.00 → $9.00Outperform
    SVB Leerink
    2/2/2022$6.50Speculative Buy → Buy
    WBB Securities
    9/9/2021$14.00Outperform
    SVB Leerink
    More analyst ratings